Karyopharm Therapeutics Inc. Quarterly Other Liabilities, Noncurrent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Karyopharm Therapeutics Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q1 2014 to Q3 2024.
  • Karyopharm Therapeutics Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2024 was $6.18M, a 333% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.18M +$4.76M +333% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $4.28M +$1.85M +75.8% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.58M +$1.5M +138% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $978K +$978K Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $1.43M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.44M Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $1.09M Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $0 Dec 31, 2022 10-K 2024-02-29
Q2 2014 $151K Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $170K Mar 31, 2014 10-Q 2014-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.